Delivery Order 75N95022D00020-75N95022F00001
Award Date 9/22/22
Potential Completion Date 9/21/27
Potential Value $22K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Cape Fear, NC 28401, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- PPD Development LP was awarded a $93,000 delivery order against an unspecified governmentwide acquisition contract by the National Institutes of Health's National Institute on Drug Abuse. The delivery order is for clinical site and study monitoring services in support of the Research Partnerships for Global Mental Health program. Performance will take place in Cape Fear, North Carolina over a one year period concluding in September 2024. The contract utilizes labor hour pricing and has no set...
- This federal contract award is for regulatory consulting assistance and research and development for clinical studies in the Blueprint MedTech program, which is managed by the National Institute on Drug Abuse (NIDA), a civilian agency. The award was made to PPD Development LP, a global contract research organization (CRO) and subsidiary of Thermo Fisher Scientific. The contract has a period of performance from September 15, 2023 to September 14, 2024, with a ceiling value of $64,107.00. This...
- This is a $324,420.00 firm fixed-price delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to PPD Development LP, a global contract research organization (CRO). The contract is for research and development services related to clinical studies in the Blueprint MedTech program, including clinical study protocol development. The contract has a 5-year period of performance from June 17, 2024 to June 16, 2029, with a base period and two option units. PPD...
- This is a firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract, valued at $696,693.16, was awarded to PPD Development LP, a global contract research organization (CRO), to provide PPD development site and study monitoring services. The contract has no set-aside designation and is part of several indefinite delivery...
- This is a $3,265,588.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS), to PPD Development LP, a global contract research organization. The contract is for a first-in-human randomized, double-blind, placebo-controlled single ascending dose (SAD) Phase I study on the development of neurotherapeutics. The contract is not set aside and is...
- This is a $3,358,776 cost-plus-fixed-fee Delivery Order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to PPD Development LP, a global contract research organization (CRO). The award is for a Phase I randomized, double-blind, placebo-controlled study to assess the safety, tolerability, and pharmacokinetics of a medical product. The contract is a task order under NIDA's "Phase I Clinical Trials for Development of Neurotherapeutics" Indefinite...
- PPD Development LP, a global contract research organization and subsidiary of Thermo Fisher Scientific, was awarded a delivery order valued at $2.79M by the National Institute of Allergy and Infectious Diseases (NIAID) on June 29, 2023. This task order falls under the Early Phase Clinical Trial Units (EPCTU) Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle, which represents a $346M master agreement designed to support early-stage clinical research across multiple therapeutic...
- This is a $32,848 firm fixed-price delivery order awarded to Actuated Medical, Inc., a woman-owned small business, by the National Institute on Drug Abuse (NIDA). The task order is for research and development services related to biocompatibility testing, animal studies, and sterilization testing for medical technologies, with a period of performance from July 14, 2025 to January 13, 2026. This task order is issued under a larger $35 million Indefinite Delivery Contract (IDC) that supports...
- This is a delivery order issued under a $35 million Indefinite Delivery Contract (IDC) between Actuated Medical, Inc. (a woman-owned small business based in Bellefonte, Pennsylvania) and the National Institute on Drug Abuse (NIDA). The contract supports the Blueprint MedTech (BPMT) Initiative, which aims to develop innovative medical technologies for nervous system disorders. This specific delivery order, valued at $81,702, is for research and development services related to biocompatibility...
- This contract award to PPD Development LP by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), is for Phase I clinical trials in the development of neurotherapeutics. The $433,977 firm-fixed-price delivery order is part of a larger indefinite delivery/indefinite quantity (ID/IQ) contract for this program area. The contract supports administrative and overall clinical operations, with a period of performance through June 30,...